|
|
|
ix | |
| Preface |
|
xiii | |
| Acknowledgement |
|
xv | |
|
|
|
1 | (8) |
|
|
|
1 | (1) |
|
|
|
2 | (2) |
|
|
|
4 | (1) |
|
|
|
5 | (1) |
|
|
|
6 | (1) |
|
|
|
7 | (2) |
|
2 Principles of cancer diagnosis and staging |
|
|
9 | (12) |
|
Securing a tissue diagnosis |
|
|
9 | (1) |
|
Principles of cancer staging |
|
|
10 | (6) |
|
|
|
16 | (5) |
|
3 Decision-making and communication |
|
|
21 | (14) |
|
|
|
21 | (3) |
|
|
|
24 | (1) |
|
|
|
24 | (3) |
|
Clinical evidence and clinical trials |
|
|
27 | (8) |
|
4 Principles of surgical oncology |
|
|
35 | (4) |
|
Management of the primary tumour |
|
|
35 | (1) |
|
Combined surgery and radiotherapy |
|
|
35 | (1) |
|
Management of regional lymph nodes |
|
|
36 | (1) |
|
|
|
37 | (2) |
|
5 Principles of radiotherapy |
|
|
39 | (12) |
|
|
|
39 | (1) |
|
Biological actions of ionizing radiation |
|
|
39 | (1) |
|
|
|
40 | (2) |
|
Clinical use of radiotherapy |
|
|
42 | (4) |
|
Side effects of radiotherapy |
|
|
46 | (1) |
|
|
|
47 | (4) |
|
6 Principles of systemic treatment |
|
|
51 | (16) |
|
|
|
51 | (4) |
|
|
|
55 | (1) |
|
Administration of chemotherapy |
|
|
56 | (4) |
|
|
|
60 | (2) |
|
|
|
62 | (1) |
|
|
|
62 | (1) |
|
|
|
63 | (1) |
|
Experimental chemotherapy |
|
|
63 | (4) |
|
7 Lung cancer and mesothelioma |
|
|
67 | (22) |
|
|
|
67 | (16) |
|
|
|
83 | (6) |
|
|
|
89 | (26) |
|
|
|
89 | (1) |
|
|
|
89 | (1) |
|
|
|
90 | (2) |
|
|
|
92 | (1) |
|
|
|
93 | (2) |
|
|
|
95 | (1) |
|
|
|
96 | (1) |
|
|
|
96 | (2) |
|
|
|
98 | (1) |
|
|
|
98 | (12) |
|
|
|
110 | (2) |
|
|
|
112 | (1) |
|
|
|
113 | (2) |
|
9 Gastrointestinal cancer |
|
|
115 | (38) |
|
Carcinoma of the oesophagus |
|
|
115 | (6) |
|
|
|
121 | (5) |
|
Carcinoma of the pancreas |
|
|
126 | (5) |
|
|
|
131 | (4) |
|
|
|
135 | (3) |
|
Carcinoma of the gallbladder |
|
|
138 | (1) |
|
Carcinoma of the colon and rectum |
|
|
138 | (8) |
|
|
|
146 | (3) |
|
Tumours of the peritoneum |
|
|
149 | (4) |
|
|
|
153 | (26) |
|
|
|
153 | (3) |
|
|
|
156 | (9) |
|
|
|
165 | (5) |
|
|
|
170 | (4) |
|
|
|
174 | (5) |
|
|
|
179 | (22) |
|
|
|
179 | (6) |
|
|
|
185 | (3) |
|
|
|
188 | (4) |
|
|
|
192 | (2) |
|
|
|
194 | (2) |
|
|
|
196 | (5) |
|
|
|
201 | (16) |
|
|
|
204 | (2) |
|
|
|
206 | (1) |
|
|
|
206 | (1) |
|
|
|
207 | (1) |
|
|
|
208 | (1) |
|
|
|
209 | (1) |
|
|
|
209 | (1) |
|
|
|
210 | (1) |
|
|
|
210 | (1) |
|
|
|
211 | (1) |
|
|
|
211 | (1) |
|
|
|
211 | (1) |
|
|
|
211 | (2) |
|
|
|
213 | (4) |
|
|
|
217 | (14) |
|
Carcinoma of the oral cavity |
|
|
217 | (6) |
|
Carcinoma of the oropharynx |
|
|
223 | (1) |
|
|
|
223 | (1) |
|
Carcinoma of the hypopharynx |
|
|
224 | (1) |
|
Carcinoma of the nasopharynx |
|
|
225 | (1) |
|
Carcinoma of the paranasal sinuses |
|
|
226 | (1) |
|
|
|
226 | (2) |
|
|
|
228 | (3) |
|
|
|
231 | (14) |
|
|
|
231 | (7) |
|
Tumours of the parathyroid gland |
|
|
238 | (1) |
|
Tumours of the adrenal glands |
|
|
238 | (2) |
|
|
|
240 | (3) |
|
Multiple endocrine neoplasia (MEN) |
|
|
243 | (2) |
|
|
|
245 | (14) |
|
|
|
245 | (5) |
|
|
|
250 | (4) |
|
|
|
254 | (2) |
|
|
|
256 | (3) |
|
|
|
259 | (20) |
|
|
|
259 | (7) |
|
Non-Hodgkin lymphoma (NHL) |
|
|
266 | (13) |
|
17 Haematological malignancy |
|
|
279 | (22) |
|
|
|
279 | (11) |
|
|
|
290 | (11) |
|
|
|
301 | (16) |
|
|
|
301 | (1) |
|
Central nervous system tumours |
|
|
301 | (3) |
|
Bone and soft-tissue tumours |
|
|
304 | (2) |
|
|
|
306 | (1) |
|
|
|
307 | (3) |
|
Nephroblastoma (Wilms' tumour) |
|
|
310 | (2) |
|
|
|
312 | (5) |
|
|
|
317 | (14) |
|
Squamous and basal cell carcinoma |
|
|
317 | (6) |
|
|
|
323 | (5) |
|
|
|
328 | (1) |
|
|
|
328 | (3) |
|
20 Carcinoma of unknown primary |
|
|
331 | (6) |
|
21 Oncological emergencies |
|
|
337 | (12) |
|
|
|
337 | (1) |
|
Spinal cord and cauda equina compression |
|
|
338 | (2) |
|
Superior vena cava obstruction |
|
|
340 | (2) |
|
|
|
342 | (1) |
|
|
|
343 | (1) |
|
Toxicities related to immunotherapy agents |
|
|
343 | (6) |
|
|
|
349 | (12) |
|
|
|
349 | (6) |
|
|
|
355 | (2) |
|
|
|
357 | (4) |
| Appendix 1 Worldwide cancer burden - males and females |
|
361 | (2) |
| Appendix 2 Worldwide cancer burden - males |
|
363 | (2) |
| Appendix 3 Worldwide cancer burden - females |
|
365 | (2) |
| Appendix 4 Answers to self-assessment questions |
|
367 | (2) |
| Index |
|
369 | |
Lisainfo e-raamatute kohta